Game-Changer for cervical cancer: Same-Day Self-Test and AI triage could save millions

NCT ID NCT07232355

Recruiting now Prevention Sponsor: Atila Biosystems Inc. Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated Apr 24, 2026 · Updated 15 times

Summary

This study aims to prevent cervical cancer by using a rapid HPV test that women can do themselves, combined with AI-powered imaging, all in one visit. It will enroll 5,000 women in Honduras to see if this approach is accurate, feasible, and cost-effective compared to current methods. The goal is to make screening and treatment faster and more accessible, especially in low-resource areas.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atila Biosystems, Inc.
RECRUITING

Sunnyvale, California, 94085, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Basic Health International
RECRUITING

San Salvador, El Salvador

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centro de Salud Las Crucitas
RECRUITING

Tegucigalpa, Honduras

Contact Email: •••••@•••••
Ciudad Mujer Kennedy
RECRUITING

Tegucigalpa, Honduras

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HUMAN PAPILLOMA VIRUS